Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins.
Subcultured endothelial cells from human umbilical veins respond to histamine and melittin with increased prostacyclin production, measured as 6-keto-prostaglandin F1 alpha by radioimmunoassay. However, no response to leukotriene C4 was observed. Primary cultured cells, on the other hand, respond to leukotriene C4 and the histamine response was 7 times more potent for these cells than for subcultured cells. In contrast, neither primary cultures nor subcultures of endothelial cells released prostacyclin following application of either human anaphylatoxin C5a (100 nM) or C3a (1 microM). In addition, these endothelial cells appear to have no specific binding sites for 125I-C5a. However, endothelial cells released prostacyclin in the presence of human polymorphonuclear leukocytes that were activated with C5a. We conclude that involvement of endothelial cells in the haemodynamic response to anaphylatoxin is an indirect function, i.e. C5a activates circulating or tissue cells which in turn stimulate the endothelial cell to produce prostacyclin.
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism*; D002478:Cells, Cultured; D003176:Complement C3 / Q000494:pharmacology; D015926:Complement C3a; D003182:Complement C5 / Q000494:pharmacology*; D015936:Complement C5a; D004727:Endothelium / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D009504:Neutrophils / Q000276:immunology; D011951:Receptors, Complement / Q000032:analysis; D013189:SRS-A / Q000494:pharmacology; D014471:Umbilical Veins / Q000166:cytology
D003176:Complement C3; D003182:Complement C5; D011951:Receptors, Complement; D013189:SRS-A; D015121:6-Ketoprostaglandin F1 alpha; D015926:Complement C3a; D015936:Complement C5a